Loading…
Korro Bio, Inc. is projected to rise to $11.50 by 2027, a +11% move from its current price of $10.37. KRRO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $9.98 | $10.37 | $10.77 | -0.03% |
| Aug 5 | $9.82 | $10.36 | $10.94 | -0.05% |
| Aug 6 | $9.70 | $10.36 | $11.07 | -0.08% |
| Aug 7 | $9.59 | $10.36 | $11.19 | -0.11% |
| Aug 8 | $9.50 | $10.36 | $11.28 | -0.13% |
| Aug 9 | $9.42 | $10.35 | $11.37 | -0.16% |
| Aug 10 | $9.35 | $10.35 | $11.46 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.35 | $10.35 | $11.46 | -0.19% |
| Week 2 | $8.95 | $10.33 | $11.93 | -0.37% |
| Week 3 | $8.65 | $10.31 | $12.29 | -0.55% |
| Week 4 | $8.40 | $10.29 | $12.61 | -0.74% |
| Week 5 | $8.19 | $10.27 | $12.89 | -0.92% |
| Week 6 | $8.00 | $10.26 | $13.15 | -1.11% |
| Week 7 | $7.83 | $10.24 | $13.39 | -1.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Korro Bio, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.
Its lead product candidate is KRRO-121 for the treatment of hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA, to generate differentiated RNA editing product candidates. The company has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases.
Korro Bio was founded in 2018 and is based in Cambridge, Massachusetts. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications.
Korro Bio, Inc. (KRRO) is currently priced at $10.64 with a market capitalization of $153.46M and is ranked 3775.
The stock trades within a 30-day price range of $8.13 to $13.92.
Forecasts show upside potential across the coming years. The 2026 forecast lists an average price of $10.64 with 0% ROI, while 2030 shows an average price of $18.81 with 76.8% ROI. 2050 projects an average price of $65.20 with 512.8% ROI.
The forecast also provides year-by-year min/max values, including 2026 min $8.00 / max $12.94 and 2030 min $12.76 / max $30.05, culminating in 2050 min $29.34 / max $142.68.
These figures suggest notable upside potential in the long term, aligned with bullish outlooks in later years.
A major floor 31.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 41.9% above — a clean break opens room to run.
A major ceiling 57.9% above — clearing it would confirm fresh momentum.
Key KRRO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRRO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.42 | Sell | $10.52 | Sell |
| MA 10 | $10.94 | Sell | $11.00 | Sell |
| MA 20 | $12.30 | Sell | $11.65 | Sell |
| MA 50 | $12.19 | Sell | $12.10 | Sell |
| MA 100 | $12.25 | Sell | $12.53 | Sell |
| MA 200 | $14.01 | Sell | $14.69 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.77 | Neutral |
| Stoch RSI (14) | 19.76 | Buy |
| CCI (20) | -94.57 | Neutral |
| Williams %R (14) | -90.62 | Info |
| MACD (12,26,9) | -0.28 | Sell |
| ROC (12) | -20.41 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 9.38 | Buy |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -2.05 | Sell |
| Ultimate (7,14,28) | 21.85 | Buy |
| Momentum (10) | -1.88 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 10.05 | Buy |
| ADX (14) | 20.76 | Sell |
| ATR (14) | 0.40 | Info |
Bearish sentiment dominates near term with RSI14 at 40. The stock is trading below key moving averages, with SMA50 at $12.19 and SMA200 at $15.06.
Near support sits at $10.53 and resistance at $14.72, indicating limited upside pressure in the immediate horizon. The 30-day price range is $8.13 to $13.92, and annualized volatility is 80%.
Overall, near-term dynamics point to caution while volatility remains elevated.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.00 | $10.37 | $12.42 | 0% | Neutral | |
| $8.83 | $11.50 | $16.01 | +11% | Neutral | |
| $9.07 | $12.31 | $18.02 | +19% | Neutral | |
| $10.84 | $15.23 | $23.17 | +47% | Bullish | |
| $12.21 | $17.69 | $27.79 | +71% | Bullish | |
| $11.42 | $17.03 | $27.50 | +64% | Bullish | |
| $11.20 | $17.15 | $28.38 | +65% | Bullish | |
| $10.92 | $17.15 | $29.02 | +65% | Bullish | |
| $11.86 | $19.07 | $32.93 | +84% | Bullish | |
| $15.12 | $24.89 | $43.81 | +140% | Bullish | |
| $15.70 | $28.79 | $54.78 | +178% | Bullish | |
| $27.19 | $60.43 | $128.48 | +483% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.00 | $10.37 | $11.92 | +0.00% |
| September 2026 | $8.25 | $9.87 | $12.23 | -4.80% |
| October 2026 | $8.38 | $10.12 | $12.72 | +2.54% |
| November 2026 | $8.05 | $9.80 | $12.47 | -3.15% |
| December 2026 | $7.87 | $9.66 | $12.42 | -1.48% |
Click any year to see its month-by-month KRRO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, KRRO could reach as high as $12.42, with a base case around $10.37 and support toward $8.00 — roughly 0% from $10.37. A consolidation phase looks the most probable path here.
Expect KRRO to range from $8.83 to $16.01 through 2027. The $11.50 average target implies a +11% move from current prices. That is up +11% on the projected 2026 average. Price action looks broadly range-bound.
The KRRO price prediction for 2028 points to an average of $12.31 (low $9.07, high $18.02) — a potential gain of +19% on today's $10.37. A consolidation phase looks the most probable path here.
In 2029, KRRO is projected to trade between $10.84 and $23.17, averaging $15.23 — a potential gain of +47% from today's $10.37. That is up +24% on the projected 2028 average. Momentum favours further upside here.
Korro Bio, Inc.'s 2030 outlook centres on $17.69, within a $12.21 to $27.79 range. That is up +16% on the projected 2029 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, KRRO could reach as high as $27.50, with a base case around $17.03 and support toward $11.42 — roughly +64% from $10.37. Momentum favours further upside here.
Expect KRRO to range from $11.20 to $28.38 through 2032. The $17.15 average target implies a +65% move from current prices. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The KRRO price prediction for 2033 points to an average of $17.15 (low $10.92, high $29.02) — a potential gain of +65% on today's $10.37. Momentum favours further upside here.
In 2034, KRRO is projected to trade between $11.86 and $32.93, averaging $19.07 — a potential gain of +84% from today's $10.37. That is up +11% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Korro Bio, Inc.'s 2035 outlook centres on $24.89, within a $15.12 to $43.81 range. That is up +31% on the projected 2034 average. That marks a +140% change versus current levels. Momentum favours further upside here.
By 2040, KRRO could reach as high as $54.78, with a base case around $28.79 and support toward $15.70 — roughly +178% from $10.37. Buyers look set to stay in control over this stretch.
Expect KRRO to range from $27.19 to $128.48 through 2050. The $60.43 average target implies a +483% move from current prices. That is up +110% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in KRRO today (≈ 96.432015 KRRO) could be worth
$5,827.14
+$4,827.14 (+483%) by 2050 · US Dollar
Based on the average projected KRRO price of $60.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRROwould be worth at today's price.
$1,000 invested in KRRO on Jul 31, 2025 (≈ 66.84492 KRRO) would be worth
$693.18
-$306.82 (-30.7%) today · 0.69× · US Dollar
Based on a KRRO entry price of $14.96 vs. today's $10.37.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.64 | $974.62 | -2.5% |
| 1 month ago | $13.65 | $759.71 | -24.0% |
| 3 months ago | $13.57 | $764.19 | -23.6% |
| 6 months ago | $13.05 | $794.64 | -20.5% |
| 1 year ago | $14.96 | $693.18 | -30.7% |
| All time (5.0y) ago | $415 | $24.99 | -97.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRRO forecast.
Our base-case forecast reaches $21.00 around 2035.
Implied market cap at $21.00: $302.87M
The multi-year forecast points to a shift from neutral to bullish sentiment beginning in the latter part of the decade. In 2029 the average price is $16.10 with 51.3% ROI, and in 2030 the average price rises to $18.81 with 76.8% ROI, signaling meaningful upside as conditions evolve.
From 2035 onward, the model shows continued upside with an average of $26.79 (ROI 151.8%) in 2035 and $29.80 (ROI 180.1%) in 2040, culminating in an average of $65.20 (ROI 512.8%) by 2050, with sentiment remaining BULLISH.
These trajectories illustrate substantial longer-term upside potential, but they reflect estimates rather than guarantees. The near-term path contains neutral to bearish signals before the later-year bull case develops, and outcomes depend on factors not captured here.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $18.81 with a maximum of $30.05 and a minimum of $12.76, and a projected ROI of 76.8% with bullish sentiment.
The forecast includes bullish sentiment from 2029 onward, with a 2030 average price of $18.81 and ROI of 76.8%, and by 2050 an average price of $65.20 with ROI of 512.8%. Near term (2026) shows a neutral outlook with an average price of $10.64 and ROI of 0%.
Yes, the 2030 forecast lists a maximum of $30.05.
The 30-day range is $8.13 to $13.92.
Current price is $10.64 and market cap is $153.46M.
Korro Bio, Inc. Community Discussion
0Share your Korro Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.